Neurocrine Biosciences Total Assets 2010-2024 | NBIX

Neurocrine Biosciences total assets for the quarter ending September 30, 2024 were $3.535B, a 24.11% increase year-over-year.

  • Neurocrine Biosciences total assets for 2023 were $3.251B, a 37.27% increase from 2022.
  • Neurocrine Biosciences total assets for 2022 were $2.369B, a 14.29% increase from 2021.
  • Neurocrine Biosciences total assets for 2021 were $2.073B, a 19.47% increase from 2020.

Neurocrine Biosciences Total Assets 2010-2024 | NBIX

  • Neurocrine Biosciences total assets for 2023 were $3.251B, a 37.27% increase from 2022.
  • Neurocrine Biosciences total assets for 2022 were $2.369B, a 14.29% increase from 2021.
  • Neurocrine Biosciences total assets for 2021 were $2.073B, a 19.47% increase from 2020.